Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout. (2017)
Attributed to:
Centre for Drug Safety Science (CDSS)
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/rheumatology/kex253
PubMed Identifier: 28957559
Publication URI: http://europepmc.org/abstract/MED/28957559
Type: Journal Article/Review
Volume: 56
Parent Publication: Rheumatology (Oxford, England)
Issue: 10
ISSN: 1462-0324